Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Nurx Announces New Chief Medical Officer as It Continues Expansion into New Categories of Care

The largest female-focused digital health practice brings on telehealth pioneer and primary care expert, Dr. Jennifer Peña, as it follows through on the business's record growth


News provided by

Nurx

Mar 01, 2021, 07:00 ET

Share this article

Share toX

Share this article

Share toX


SAN FRANCISCO, March 1, 2021 /PRNewswire-PRWeb/ -- Nurx, the telehealth platform providing convenient and affordable care for female health needs, today announced that Dr. Jennifer Peña will join the company as Chief Medical Officer. Dr. Peña brings deep experience in telehealth, expertise in primary care, and a passion for expanding access to high-quality healthcare at scale. As Chief Medical Officer, she will help Nurx build upon its record year of growth and begin treating multiple new conditions, while maintaining the highest quality of patient care.

Jennifer M. Peña, MD, is an internal medicine doctor, Army veteran, former physician to the White House Medical Unit, and a trailblazer in digital and telehealth. Dr. Peña joins Nurx from Oscar, where she served as Medical Director for Virtual Primary Care, while also consulting for Private Medical, Global Executive Medicine, and the INOVA VIP 360 executive medical practice, and working as a hospitalist to respond to the Covid-19 pandemic. As an Army physician, Dr. Peña served a tour of duty at the White House Medical Unit under both the Obama and Trump administrations, running a clinic in the Eisenhower Executive Office Building, acting as Medical Director at Camp David, and serving as Physician to the Vice President. Dr. Peña's Army experience also included tours of duty as Medical Director at Fort Belvoir Community Hospital and a deployment to Afghanistan in 2012. A native of Puerto Rico, Dr. Peña received her undergraduate degree from Yale University and her medical degree at the University of Pittsburgh School of Medicine before entering active duty in the US Army in 2008 and completing an internal medicine residency at Walter Reed Army Medical Center.

...As I bring my experience to leading the highly credentialed and mission-driven Nurx medical team, I am incredibly optimistic about using telehealth to treat more people for more conditions and in turn to measurably improve lives.

Post this

"From practicing medicine via telehealth since I was a resident at Walter Reed assisting with care of patients in combat zones, to my work at the White House using remote diagnostics to provide worldwide care to our nation's leaders, and recently scaling primary care at a digital-first health insurance innovator, I've always found it exciting to help lead the progress and transformation of teleconsultation and digital health," said Dr. Peña. "As I bring my experience to leading the highly credentialed and mission-driven Nurx medical team, I am incredibly optimistic about using telehealth to treat more people for more conditions and in turn to measurably improve lives."

After a year of record growth, Nurx expands into new areas of care.

Dr. Peña joins at a time when Nurx is experiencing rapid growth, fueled by patients turning to telehealth during the COVID-19 pandemic and discovering that it's a more convenient and cost-effective way to receive high-quality medical care for many of their personal health conditions. In 2020, Nurx experienced a 50% increase in requests for birth control, a 100% increase in home STI testing, an almost 200% increase in requests for herpes treatment, and a 300% increase in emergency contraception requests. Nurx has provided 1 million medical consultations and has had 7 million touchpoints with patients.

"The pandemic accelerated trends that were already driving the growth of telehealth, such as patients being less tethered to a primary care physician and expecting to have nearly everything delivered," says Nurx CEO Varsha Rao. "Many who tried telehealth in a pinch during the pandemic, or who formerly saw virtual care as secondary to in-person care, are now turning to telehealth first. Bringing on Jennifer Peña as Chief Medical Officer helps us ensure that we are prepared to deliver these patients the highest-quality of care, and meet their demand for more types of care."

This month Nurx will launch acne treatment, as a first step to making care for common dermatological conditions more broadly accessible. More than half of Nurx's current patients have told the medical team that they struggle with acne, and because acne is often caused by hormonal fluctuations and treated with birth control Nurx healthcare providers are uniquely qualified to help patients improve their skin. Nurx will treat acne with prescription medications — both topical treatments and oral medications including antibiotics, spironolactone and combination birth control — which the Nurx pharmacy will fill and mail to patients' homes. If a new patient is already taking hormonal birth control, a Nurx medical provider will advise them on whether their contraceptive formula is the best one for their skin.

To put expert acne treatment within reach for patients who may not be able to afford it otherwise, Nurx will bill insurance where possible for acne medications and work to keep out-of-pocket prices low. Approximately half of current Nurx patients pay for their medications and lab orders with insurance, and the ability to do so differentiates Nurx from other companies in the telehealth space.

Acne treatment is the latest Nurx service aimed at opening up access to care for conditions that are common among women, and for which in-person care is often prohibitively expensive or inconvenient. In the fall Nurx launched treatment for migraines and chronic tension headaches to address the fact that many of their 350,000 birth control patients experience migraines, and that pandemic-related stress and increased screen time have been making migraines worse. 70% of Nurx's headache and migraine patients were already using Nurx for at least one other service.

"I'm passionate about expanding services across the spectrum of the female healthcare journey, and creating a telehealth platform that seamlessly meets women's health needs throughout the different stages of their lives," says Dr. Peña. "The Nurx integrated platform has improved access to medication and tests for one million patients, and I look forward to leading the medical team as we make healthcare accessible, affordable, and all-around better for millions more."

About Nurx

Nurx is a health tech company providing convenient, affordable, and personalized care for sensitive health needs. By reimagining the healthcare experience, Nurx offers patients transparent pricing and judgment-free care whenever and wherever works best for them. Nurx believes everyone should have the freedom to live well and be in charge of their healthcare decisions, regardless of their circumstances. From diagnosis to delivery, Nurx makes every part of getting healthy and staying healthy, better.

Media Contact

Ann Noder, Pitch Public Relations, +1 480.263.1557, [email protected]

SOURCE Nurx

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.